Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Chronic Rhinosinusitis
100%
COVID-19
80%
Olfaction
60%
Quality of Life
56%
Nasal Polyp
54%
Functional Endoscopic Sinus Surgery
51%
Postoperative Pain
47%
Meta-Analysis
44%
Neoplasm
44%
Randomized Clinical Trials
43%
Inflammation
42%
Diseases
40%
Liquorrhea
39%
Systemic Disease
39%
Rhinology
39%
Xerostomia
39%
Eosinophilia
39%
Neutrophilia
39%
Skull Surgery
39%
Stellate Ganglion Block
39%
Parosmia
39%
Surgery
34%
Analgesia
33%
Radiation Therapy
31%
Sphenoid
29%
Otorhinolaryngology
29%
Tumor
29%
Transsphenoidal Surgery
28%
Placebo
27%
Prospective Cohort Study
27%
Morphine
27%
Paranasal Sinus
26%
Skull Base
26%
Anosmia
24%
Prognostic Factor
24%
Systematic Review
24%
Malignant Neoplasm
24%
Cochlea
24%
Perioperative Period
23%
Polyp
23%
Cohort Analysis
22%
Neck
22%
Nasal Cavity
21%
Overall Survival
21%
Fungal Sinusitis
19%
Dilation Procedure
19%
Medicare
19%
Eosinophilic Granulomatosis with Polyangiitis
19%
Theophylline
19%
Connective Tissue Cancer
19%
Keyphrases
Olfactory Dysfunction
68%
Sinus
63%
Cerebrospinal Fluid Leak
59%
Invasive Fungal Sinusitis
59%
Parosmia
59%
COVID-19
53%
Xerostomia
44%
Meta-analysis
44%
Rhinology
43%
Radiation-induced Xerostomia
39%
Postoperative Pain
39%
Balloon Sinus Dilation
39%
Sinonasal
35%
Otolaryngologist
32%
Tumor
30%
Surgical Management
29%
Paranasal Sinuses
28%
Patient Care
28%
Head-and-neck Cancer
27%
Postoperative Pain Management
26%
Endoscopic Endonasal
26%
Skull Base
26%
Pain Control
26%
Stellate Ganglion Block
24%
Chronic Rhinosinusitis
24%
Hyperbaric Oxygen
23%
Preoperative Computed Tomography
23%
Opioid Use
23%
After Surgery
23%
Prospective Cohort Study
23%
Anosmia
22%
Olfactory Test
22%
Head-and-neck
22%
Randomized Clinical Trial
22%
Sphenoid
21%
Overall Survival
20%
Systemic Disease
19%
Inflammation
19%
Coronavirus Disease (COVID)
19%
Endoscopic Sinus Surgery
19%
Sinusitis
19%
Survival Outcomes
19%
Pharmacovigilance
19%
Consensus Statement
19%
Specific Performance
19%
Conduction System
19%
Healthcare Decision-making
19%
Hereditary Hemorrhagic Telangiectasia
19%
International Consensus
19%
Novel Imaging
19%